204 related articles for article (PubMed ID: 21627048)
21. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
23. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of anti-viral responses in intestinal epithelial cells by epigenetic modifying drugs is mediated by a reduction in viral pattern recognition receptor expression and activity.
Hennessy C; O'Connell S; Egan LJ; McKernan DP
Immunopharmacol Immunotoxicol; 2019 Oct; 41(5):527-537. PubMed ID: 31505962
[No Abstract] [Full Text] [Related]
25. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.
Falkenberg KJ; Johnstone RW
Nat Rev Drug Discov; 2014 Sep; 13(9):673-91. PubMed ID: 25131830
[TBL] [Abstract][Full Text] [Related]
28. The promise and failures of epigenetic therapies for cancer treatment.
Bojang P; Ramos KS
Cancer Treat Rev; 2014 Feb; 40(1):153-69. PubMed ID: 23831234
[TBL] [Abstract][Full Text] [Related]
29. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.
Gore SD; Baylin S; Sugar E; Carraway H; Miller CB; Carducci M; Grever M; Galm O; Dauses T; Karp JE; Rudek MA; Zhao M; Smith BD; Manning J; Jiemjit A; Dover G; Mays A; Zwiebel J; Murgo A; Weng LJ; Herman JG
Cancer Res; 2006 Jun; 66(12):6361-9. PubMed ID: 16778214
[TBL] [Abstract][Full Text] [Related]
30. H3K9 trimethylation precedes DNA methylation during sheep oogenesis: HDAC1, SUV39H1, G9a, HP1, and Dnmts are involved in these epigenetic events.
Russo V; Bernabò N; Di Giacinto O; Martelli A; Mauro A; Berardinelli P; Curini V; Nardinocchi D; Mattioli M; Barboni B
J Histochem Cytochem; 2013 Jan; 61(1):75-89. PubMed ID: 23019017
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
Ye CG; Chen GG; Ho RLK; Merchant JL; He ML; Lai PBS
Biochim Biophys Acta; 2013 Dec; 1833(12):2970-2979. PubMed ID: 23954442
[TBL] [Abstract][Full Text] [Related]
32. Epigenomes as therapeutic targets.
Hamm CA; Costa FF
Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
[TBL] [Abstract][Full Text] [Related]
33. [DNA methyltransferase inhibitors * histone deacetylase inhibitors].
Kikuchi J; Furukawa Y
Nihon Rinsho; 2014 Jun; 72(6):1136-42. PubMed ID: 25016817
[TBL] [Abstract][Full Text] [Related]
34. Emerging epigenetic targets and therapies in cancer medicine.
Popovic R; Licht JD
Cancer Discov; 2012 May; 2(5):405-13. PubMed ID: 22588878
[TBL] [Abstract][Full Text] [Related]
35. Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation.
Peng Z; Zhou W; Zhang C; Liu H; Zhang Y
Med Sci Monit; 2018 Jan; 24():461-472. PubMed ID: 29363667
[TBL] [Abstract][Full Text] [Related]
36. Expression pattern of DNA-methyltransferases and its health implication (short review).
Kvaratskhelia E; Tkemaladze T; Abzianidze E
Georgian Med News; 2014 Mar; (228):76-81. PubMed ID: 24743128
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
38. Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications.
Hori Y; Kikuchi K
Acc Chem Res; 2019 Oct; 52(10):2849-2857. PubMed ID: 31577127
[TBL] [Abstract][Full Text] [Related]
39. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
Mohammad HP; Barbash O; Creasy CL
Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
[TBL] [Abstract][Full Text] [Related]
40. DNA methyltransferase 1(DNMT1) induced the expression of suppressors of cytokine signaling3 (Socs3) in a mouse model of asthma.
Verma M; Chattopadhyay BD; Kumar S; Kumar K; Verma D
Mol Biol Rep; 2014 Jul; 41(7):4413-24. PubMed ID: 24599782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]